4D Molecular Therapeutics (FDMT)
(Real Time Quote from BATS)
$23.73 USD
-0.52 (-2.14%)
Updated Apr 25, 2024 03:30 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.73 |
EPS Last Quarter | -0.77 |
Last EPS Surprise | -13.24% |
ABR | 1.10 |
Earnings ESP
|
-8.22% |
---|---|
Current Year | -3.03 |
Next Year | -3.15 |
EPS (TTM) | -2.66 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.44M | 1.45M | 5.65M | 11.76M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 3.30M | 3.30M | 13.00M | 16.90M |
Low Estimate | 0.50M | 0.50M | 1.90M | 2.09M |
Year ago Sales | 0.30M | 0.24M | 20.72M | 5.65M |
Year over Year Growth Est. | 378.67% | 502.50% | -72.73% | 108.19% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.73 | -0.76 | -3.03 | -3.15 |
# of Estimates | 4 | 3 | 6 | 4 |
Most Recent Consensus | -0.72 | -0.75 | -3.05 | -3.53 |
High Estimate | -0.68 | -0.72 | -2.57 | -1.31 |
Low Estimate | -0.79 | -0.81 | -3.29 | -4.50 |
Year ago EPS | -0.88 | -0.77 | -2.58 | -3.03 |
Year over Year Growth Est. | 17.05% | 1.30% | -17.44% | -4.13% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.73 | -0.76 | -3.03 | -3.15 |
7 Days Ago | -0.73 | -0.76 | -3.03 | -3.15 |
30 Days Ago | -0.71 | -0.74 | -2.97 | -3.76 |
60 Days Ago | -0.69 | -0.68 | -3.02 | -3.52 |
90 Days Ago | -0.79 | -0.79 | -3.02 | -3.54 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.79 | -0.81 | -3.29 | -1.31 |
Zacks Consensus Estimate | -0.73 | -0.76 | -3.03 | -3.15 |
Earnings ESP | -8.22% | -6.58% | -8.76% | 58.41% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.77 | -0.24 | -0.77 | -0.88 | NA |
Estimate | -0.68 | -0.67 | -0.77 | -0.88 | NA |
Difference | -0.09 | 0.43 | 0.00 | 0.00 | 0.09 |
Surprise | -13.24% | 64.18% | 0.00% | 0.00% | 12.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more